Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Xia-wei Zheng"'
Publikováno v:
Frontiers in Neuroscience, Vol 12 (2018)
Background: Ischemia stroke is known as the major cause of morbidity and mortality. Buyang Huanwu Decoction (BHD), a classical traditional Chinese medicine (TCM) formula, has been used to prevent and treat stoke for hundreds of years. The purpose of
Externí odkaz:
https://doaj.org/article/a816ceaa884c46f6bde6ddccfe3e3839
Autor:
Hui-Qin Li, Yan Li, Zi-Xian Chen, Xiao-Guang Zhang, Xia-wei Zheng, Wen-ting Yang, Shuang Chen, Guo-Qing Zheng
Publikováno v:
Neural Plasticity, Vol 2016 (2016)
Spontaneous intracerebral hemorrhage (ICH) is one of the most devastating types of stroke. Here, we aim to demonstrate that electroacupuncture on Baihui (GV20) exerts neuroprotection for acute ICH possibly via the caveolin-1/matrix metalloproteinase/
Externí odkaz:
https://doaj.org/article/15dcfe03602a4f158490b98fc7e79597
Publikováno v:
Frontiers in Neuroscience
Frontiers in Neuroscience, Vol 12 (2018)
Frontiers in Neuroscience, Vol 12 (2018)
Background: Ischemia stroke is known as the major cause of morbidity and mortality. Buyang Huanwu Decoction (BHD), a classical traditional Chinese medicine (TCM) formula, has been used to prevent and treat stoke for hundreds of years. The purpose of
Autor:
Yan Lin, Yan Wang, Shuang Chen, Chun-Shuo Shan, Guo-Qing Zheng, Xiao-Yi Bao, Jia-Zhen Zhu, Qing-Qing Xu, Wen-ting Yang, Xia-wei Zheng
Publikováno v:
Biochemical pharmacology. 141
Currently, there is lack of cure or disease-modifying treatment for Alzheimer's disease (AD). Chinese herbal medicine (CHM) is purported to ameliorate AD progression, perhaps by promoting hippocampal neurogenesis. Here, we conducted an updated system
Publikováno v:
Frontiers in Neurology. 8
l-3,4-Dihydroxyphenylalanine (l-DOPA) remains the primary pharmacological agent for the symptomatic treatment of Parkinson’s disease (PD). However, the development of l-DOPA-induced dyskinesia (LID) limits the long-term use of l-DOPA for PD patient
Autor:
Wen-ting Yang, Qing-Qing Xu, Chun-Shuo Shan, Ji-Chen Ruan, Guo-Qing Zheng, Xia-wei Zheng, Shuang Chen
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2017 (2017)
Oxidative Medicine and Cellular Longevity, Vol 2017 (2017)
Neuroprotection is defined as using a therapy that affects the brain tissue in the still-viable ischemic penumbra to salvage or delay the infarction. Catalpol, the main active principle of the root of Radix Rehmanniae, was reported to have pleiotropi
Autor:
Wen-ting Yang, Xia-wei Zheng, Guo-Qing Zheng, Shuang Chen, Xiao-guang Zhang, Yan Li, Zi-xian Chen
Publikováno v:
Scientific Reports
Sham electroacupuncture (EA) control is commonly used to evaluate the specific effects of EA in randomized-controlled trials (RCTs). However, establishing an inert and concealable sham EA control remains methodologically challenging. Here, we aimed t
Autor:
Su-Bing, Yin, Xiao-Guang, Zhang, Shuang, Chen, Wen-Ting, Yang, Xia-Wei, Zheng, Guo-Qing, Zheng
Publikováno v:
Frontiers in Neurology
l-3,4-Dihydroxyphenylalanine (l-DOPA) remains the primary pharmacological agent for the symptomatic treatment of Parkinson’s disease (PD). However, the development of l-DOPA-induced dyskinesia (LID) limits the long-term use of l-DOPA for PD patient
Autor:
Wen-ting Yang, Hui-qin Li, Xiao-guang Zhang, Xia-wei Zheng, Yan Li, Zi-xian Chen, Guo-Qing Zheng, Shuang Chen
Publikováno v:
Neural Plasticity
Neural Plasticity, Vol 2016 (2016)
Neural Plasticity, Vol 2016 (2016)
Spontaneous intracerebral hemorrhage (ICH) is one of the most devastating types of stroke. Here, we aim to demonstrate that electroacupuncture on Baihui (GV20) exerts neuroprotection for acute ICH possibly via the caveolin-1/matrix metalloproteinase/
Autor:
Zi Xian Chen, Xia Wei Zheng, Shuang Chen, Yan Li, Guo-Qing Zheng, Lin Lu, Wen Ting Yang, Ji Huang Li, Xiao-guang Zhang, Yong Gu
Publikováno v:
Medicine. 95:e4904
BACKGROUND Chinese herbal medicine (CHM) has been used to treat stroke for thousands of years. The objective of the study is to assess the current evidence for bioactive components of CHM as neurogenesis agent in animal models of ischemic stroke. MET